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Using the washout phenomenon of biochemical markers. 
many investigators have reported noninvasive methods for 
detecting coronary reperfusion in patients with acute myo- 
cardial infarction. Asparlate aminottwtsbrase. lactate dehy- 
drogenase, creatine kinase (CK), MB isoenzymc (CK-MB), 
CK isofomx and myoglobin have been used for this purpose 
(I-10). Cardiac traponin T has been developed as a new 
mwcardial-specific marker (11-14). Kalus et al. $9 have 
reined that cardiac troponin T testing was mosl~useful in 
patients with myocardial damnge with superimposed skeletal 
muscle damage; its accuracy in this situation was 8946 
compared with 63% for CK.MB. They also reported that the 
ratio of cardiac troponin T concentration 14 h to that 38 h 
after the onset of acute mywudiat infarction was an excet- 
lent index of coronary repetfusion (15.16). However, be- 
caw their index cannot be caladaled wit 38 h after lhe 
onset of acute myocardiat infarction, an earlier index of 
reoerfitsiott is desirable to determine whether additional 
th’erapy is necessary for myocardii salvage. 
In the present study. we examined early asxssmcnt of 
repcrfusion therapy usiw cardiac lroponin T and CK-MB in 
patients with acute myocardiat infarction and lolat occlusion 
of the infarcbrclated cornnarY artery Chat was continned by 
comnatyangiography. - 
Methods 
RtkW md tnrlmnl. Subjects included 51 p&nts 
with acute myocardial infarction with rcpcrfusion therapy 
that was initiated within 7 h after the onset of symptoms. 
Criteria used to diagnose acute myocardial infarction were 1) 
chest pain persisting >M min and not relieved by sublingual 
nilrqlycerin and 7.) ST segment elevation >O.t mV on at 
least two adjacent eiectrwxdiagram (ECG) leads. We ex- 
cluded two psticnts with persistent shock from the present 
study because it was diacult lo perform the study pr&wl 
completely. In additiin, patients who showed spontaneous 
reperfusion of the infarct-related coronary anery before 
treatment (eight patients) and intermittent reocclusion within 
I h after successful reperfusion (threu patients) were ex- 
cluded by meam of serial coronary an_eiography. The re- 
maining 38 patients with acute myocardial infarction and 
total occlusion ofthe infarct-related coronary artery that was 
continned by coronary angiogrephy fanned the study group 
(31 men, 7 women, mea” [?SD] age 63 ? I? years. range 32 
to W). Informed consent was obtained before initiation of 
repetfosion therapy. 
In all patients, coronary angiography using the Judkins 
technique was performed before treatment and every 5 to 
8 min thereaRer. Percutaneous transluminal coronary angio- 
plasty was performed in IS patients. and thrombolytic ther- 
aov was initiated in 23. Reoerfusion of the infarct-related ., 
coronary artery was obtained in 14 patients by coronary 
angioplasty (group I) and in 12 patients by thrombolytic 
therapy (gmup 2) but was not obtained in I2 patients (group 
3). Perfusion status of the inferct-related coronary artery 
was graded according to definitions of perfusion in the 
Thmntbolysis in Myocardial Infarction (TIMI) trial (171. 
With serial coronary angiography, patency of the infarct- 
related coronary anery (TIMI grade 2 or 31 persisted from 
the onset of reperlnsion until 60 min after repcrliision in 
groups I and 2, and occlusion (TIM1 gntde 0 or Il persisted 
from the initiation of treatment until 60 min later in group 3. 
Thmmbolytic therapy consisted of intravenous infusion of 
tissue-type plasminogen nctivator (29 to 40 mgl or pro- 
umkinase (48 mg) for 60 min or intraconxary infusion of 
umkinase (3 to 6 mgl for IS to 30 min. 
Markers!. Blood samnlina was uetformed at IS-min inter. 
vals up to 60 min after’tr&tmeni was initiated in all three 
groups and at 15.min intervals up to 68 mitt aRer the onset I 
reperlusion in groups I and 2. Blood was withdrawn through 
a sheath placed in the femoral artery and was centrifuged at 
3,088 rpm for 5 min. Serum was fmzen at -8OC until 
cardiac tmponin T measurement. and plasma WBE used for 
CK-MB tneasurement. 
Serum concentration of cardiac tmponin T was measured 
with a reagent from Boehringer Mannheim on the bnsis of 
enzyme immunoassay using a batch enzyme immunoassay 
analyzer (Enzymun~teatsystem ES6CQ. Bachringer Mann- 
helm). Test procedures for cardiac troponin T have been 
reported in detail by Katus et al. (18). Plasma CK-MB 
activities were measured with a reagent from Bochringer 
Mannheim on the basis of the immunoinhibition method 
using an automatic chemical annlyaer (Hitachi 7050). In 
addi&on, CK activities were measured with an enzymatic 
method (Boehtinger Mannheim) every 3 h until 24 h after 
reperfusion to Jbtaln the peak CK level as an index of 
myowdial infarction size. Assay times of cardiac troponin 
T and CK-MB were -90 min and 10 min. respectively. In 
our laboratory. the upper limits of normal values for cardiac 
ttnponin T and CK-MB are 0.20 @ml and 25 mU/ml, 
ESpCCtiVdy. 
As an index of coronary reperfusion, increases in cardiac 
tmponin T concentrntion (Atroponin T) and CK-MB acti-ity 
(ACK-hlBl were obtained by subtracting levels at the initi- 
ation of treatment from those 60 min after treatment in all 
three groups and by subtracting levels nt the onset of 
reoerfusion from those 30 and 60 mio after noerfusion in 
groups I and 2. The Atmponin T or ACK-MB obtaining tbc 
highest predict+ zccnrncy 60 min after the initiation of 
treatment was chosen as a threshold value for detec:ing 
coronary reperfusion, and the sensitivhy, specificity and 
predictive accuracy were calculated using this threshold. 
StsLtieaI anaIysis. Datil were expressed ns mean value -c 
SD. The digerences in sewn cardiac troponin T concentta- 
tions. Atroponin T and plasma CK-MB activities or 
ACK-MB among groaps I to 3 were evaluated by multiple 
conmarison test of !he Dunn tvne. DiRerences in clinical 
cha&tistics among the three.&o”ps were evaluated by a 
multiple comynrison or chi-square test. The differences in 
sensitivity, specificity and predictive accnmcy between 
Stroponin T and ACK-MB were evaluated by the chi-square 
test. Correlations between Atroponin T and ACK-MR were 
evaluated by simple regression analysis: p < 0.05 was 
considered significant. 
Results 
Clinical chnraetcrbtlcs. The clinical charnctetistics of pb 
tients with successful coronary angioPlasty (group I), suc- 
cessful thrombolytic thenpy (group 2) and failed reperfusion 
therapy (group 3) nre shown in Table I. There were no 
significant differences in age, gender, infarct-related coro- 
nary artery, time from onset of symptoms to initiation of 
treatment or cardiac troponin T and CK-MB levels at the 
initiation of treatment among the three groups. There were 
also no significant differences in dura:ion between the onset 
of symptoms and the time of reperfusion and in levels of 
cardiac trooonin T and CK-MB at reperfnsion between 
groups I arti 2. Furthermore. the duratioi between the onset 
of symptoms and repelfusion and between levelj of cardiac 
troponin T and CK-MB at reperfusion in groups I and 2 were 
not significantly different from the duration between onset 
and initiation of treatment, and levels of cardiac tropnnin T 
and CK-MB at initiation of treatment in 8roup 3. 
Cornnary reperfusion (TIM1 grade 2 or 3) was oblained 
7 t 2 mitt after the initiation of coronary angioplasty (group 
I) and was obtained 20 * 10 min after the initiation of 
thrombolytic therapy (group 2). In groups I and 2. blood 
samples were taken I h after treatment was initiated. at 52 to 
67 min (mean 60 ? 5 mitt) because blood sampling was 
performed every I5 min after reperfusion. In group I, TIM1 
grade 3 flow was identiied in all I4 patients both 30 and 
M1 mitt after coronary angioplasty was initiated. However, in 
group 2, TIM1 grade 0 to I, 2 and 3 Rows were identified in 
two, seven and three patients, respectively, at 30 min. and 
in zero, four and eight patients, respectively, at 60 min after 
thrombolytic therapy was initiated. 
Tlmeccmr~dcardlactrqanhTLadCK-MBafW minutes after repcrfusion therapy was initiated. Atropmin T
i&l&m of Irenln~~t. In groups I and 2, serum cardiac valu% in groups I and 2 (9.35 2 7.83 and 3.23 t 3.08 nghl, 
troponin T concentrations (p C0.01) increased significantly, respectively) were sigzdhantly (p < 0.01 in group I, p < 0.05 
from 0.22 = 0.22 and 0.16 f 0.24 nglml lo 9.57 j: 7.57 and in 2) higher than those group in group 3 (0.16 t 0.19 n&U 
3.41 * 3.06 nglml, respectively, at 60 f 5 min after treatment (Fi& 2). 
was initialed. However, in group 3. serum cardiac troponin In groups I, 2 and 3, plasma CK-MB activities iocaascd 
T concentration increased from 0.23 t 0.18 to only 0.39 * from 32 2 26,31 2 17 and 35 + 15 mU/ml to 157 + 101. 161 
0.35 &m/ml M) min atIer treatment was initialed (Fig. I). Sixty t I38 and 45 + 20 mU/ml, respectively, 60 * 5 min after 
ilier W&c purl) immeheiy before and 
60 min after Ihc initiuicln of leperfusion tber- 
spy. Sixy minutes after weatmmt. bMh Imp 
nin T and CKAIB levels in groups I (!dd 
ckfa) and 2 @pm drcks) arc signihndy 
hi&r dun the in group 3 kdU squab 
‘p < 0.05; l ‘p < 0.01. Data M nxan value d 
SD. 
PIgarc 2. lncrca~r in cardiac tropanin T (ATnT) (loft panei) and 
~reatine kinssc. MB iranzyme (ACK-MB) (right pan&M) min after 
the initiation cd reperfusian Lcnpy. D&ted tines shows the rhre~h- 
old values (Atroponin T 0.53 n&t, ACK-MB 25 mIJiml) for 
defcCting COrOrW reperfurion. Both Atmponin T and ACK-MB in 
groups I and 2 are significantly higher than those in group 3. *p c 
6.65: ‘p i O.Ct. Data arc mwn value s SD. 
treatment was initiated (Fig. I). Sixty minutes at&r trcat- 
ment was Utiated. ACK-MB values in PMULIS I and 2 I 125 ? 
83 and IM f 137 mU/mI. rcspcctivciy) &rc also &ii% 
wdly (p < 0.01 in group I. p C 0.05 in group 2) higher than 
those in gmup 3 (10 + 9 mU/ml) (Fig. 2). There were 
signiiant correlations between Atmponin T and ACK-IMB 
60 min after treahnent was initiated, (r = 0.74. p < 0.001). 
Figure 3 shows the time cour~c of serum cardiac troponin 
Tmncentmtions in representative patients belonging to each 
of the three groups. In the patients from groups I and 2. 
serutt~ cardiac tmponin T concentrations were 3.73 and 
0.58 n&n1 at 30 min and 12.0 and 4.04 &ml (Atroponin T 
11.3 and 3.84 n&nl) at 68 mitt afler treatment was initiated. 
rcswctivelv. The 14shi38.h ratio of the fomtcr was 1.65. and 
that of the-latter was I.89 (data not shown). In contrast. 
serum cardiac troponin T showed little increase in a patient 
with unsuccessful repcrfusion (gmup 3). ATroponin T values 
30 and 60 min tier urokinase infusion was initiated were 
0.20 and 0.36 @ml. respectively. The 14-M8-h ratic was 
0.28 (data not shown). 
Time - of catWe trownin T and CK-MB a&r 
rep&&on. In groups I and Z.-cardiac lroponin T cancen- 
trations ICK-MB activities) increased sieniftcantlv. from 
0.23 + 0:22 nglml (32 ? 26’mLJ/ml) and 0722 ? 0% ngiml 
(39 -C 26 mU/ml) at presentation to 3.65 _’ 3.57 &ml (103 2 
71 mu/ml) and 3.07 i: 3.48 nglml(145 z !I8 mu/ml) 30 min 
Figur. 3. Indiuic’ual time course of serum cardiac tmponin T (TOT) 
concentrations in representative patients with successful coronary 
anwplrlsty wid circkk successfut thmmtmlytic therapy (open 
cimW and unsuccessful thmmbolytic therapy @&kl sqwre). Tm. 
ponin T levels in Ihe patients with repafusion increase rapidly soon 
alter reperfus~on. In cmwast, tmpmin T levels iti 3 patient without 
rrwfusiun show little increase during umkinase infusion. 
after the onset of reperfusian and 10.3 ? 8.46 ng/mt (I64 t 
IOI mu/ml) and 7.07 + 8.28 &ml (197 + 148 mu/ml) @I min 
tier reperfusion. respectively. There were no significant 
dibrences in Atroponin T and &X-MB 30 and 68 min after 
reperfusion between the two groups. In group 2, there were 
no significant differences in Atroponin T and ACLMB 30 
and 6Q min after rewfusion between xuients with TIMI 
grades 2 and 3. 
Detection of mroosry reperhsion. ATraponin T of 
0.50 &ml and ACK-MB of 25 mu/ml showed the hiehcst 
predic& accuracy for detecting coronary rep&&n 
60 min afler treatment was initiated (Fi. 2). Using these 
threshold values, the sensitivity. specificity and predictive 
accuracy 60 min after treatment was initiated and 30 and 
M1 min r&r reperfusion arc shown in Table 2. The sensitiv- 
ity, specificity and predictive accuracy for detecting reper- 
fusion using Atroponin T showed no sienificant differences 
from those using ACK-MB. 
Two patients in group 1 showed Atroponin T < 0.50 @ml 
30 min after rcperfusion, and two patients in group 2 showed 
Atropanin T < 0.50 nglml, both 60 min after treatment and 
30 min after reperfusion. In patients with Atroponin T < 
0.50 nglml. the infarct-related coronary artery was the distal 
right coronary artery in three and the diagonal coronary 
artery in one. Peak CK activities in these four patients were 
966 to 2,375 mUlml (mean 1,524 + 600 mU/ml). whereas the 
mean was 4,120 * 2,224 mu/ml in the other 22 patients with 
Atroponin T t 0.50 &ml (p < 0.05). Using ACK-MB, 
coronary rcperfusian could not also be detected in three of 
the reperfused patients. Peak CK activities in these three 
patients were 1,792 _t 1,107 mU/ml, whereas they were 
3,972 z 2,263 mu/ml in the other patients. 
Dkcussion 
We measured serum cardiac troponin T concentrutions 
and plasma CK-MB activities every I5 min in patients with 
acute myocardial infarction with attempted nperfusinn ther- 
apy. ATropunin T and ACKMB levels in the regerfused 
groups (TIM1 grade 2 or 3) were significantly higher than 
those in the nonrepetfused group (TIM1 grade 0 or 1168 min 
after treatment was initialed. The sensitivity, specificity and 
predictive accuracy of Atropmin T Xl.50 @ml as well as 
ACK-MB 225 mU/ml were loo%, 188% and 188% in pa- 
tients with successful coronary angioplasty and 92%, 188% 
and 96% in patients with successful thrombolytic therapy, 
respectively. Thus, coronary reperfusion could be detected 
accurately I h after the initiation oftreatment using increases 
in cardiac tmponin T as well as CK.MB levels not only in 
successful coronary angioplasty but also in successful 
thrombolytic therapy. 
SI@kxnee of eardlac tmponht T attd CK-MB for de&et. 
log cnmtmry reperfuslott. Clinical indicators, such as reso- 
lution of chest pain, reduction of ST segment elevation or 
occurrence of reprfusion arrythmias. have been widely 
used for noninvasive detection of coronary reperfusion. In 
recent studies, these indicators were reported to be not only 
convenient but also sensitive. Shah et al. (19) reoorted that 
chest pain resolved in 23 + 23 min and that ST segment 
elevation decreased by >Xt% within I6 t 14 min in patients 
with TIM1 grade 3 flow. 
There have been many reports of biochemical detection 
ofcoronary repelfusion on the basis ofthe washout phenom- 
enon of intramyocardial protein. Shell et al. (I) first reported 
that the average time to peak CK-MB for the conventionally 
treated group was 18.3 f 5.5 h, fur the successfully reper- 
fused group it was 9.9 + I.1 h (p < 0.001). Kwong et al. (2) 
determined the serum CK. CK-MB. asoartate aminotraus- 
ferase and lactate dehydrogenase activities in patients uo- 
dergohrg intracoronary infusion of streptokinase and re- 
ported that early peaking of CK or CK-MB levels could be 
potentially useful as a noninvasive in vitro index of the 
success of tbrombolytic therapy. Lewis et al. (IO) reported 
that a tint-hour increase in CK or CK-MB levels was found 
in patients immediately after reperfusion with TIM1 grade 3 
perfusion. Recently. mynglobin and CK isoforms were also 
reported as rapid markers of rcperfusion. Ellis et al. (3) 
reported that a tapid increase in myogInbin after successful 
reperfusii was evidenced by a >4.Cfold increase in myo- 
globin over the 1st 2 h after treatment (sensitivity 85%. 
specificity ItHY& predictive accuracy 88%). Katus et al. (4) 
reported that the optimal tIixtirinatory time htttlts for 
reperfusion were 7 h for myoglobin. 14.4 h for CK-MB and 
16 h for CK, with a prot&ility of correct classiScation of 
93%. 88% and 89%. respectively (4). With re8ard to CK-MM 
isofomts, laperche et al. (7) reported that an increase in the 
MMll/MMl ratio X35 after 68 min was very spccifie for 
rcperfusion (sensitivity 6896, speciclcity 10096). We also 
noted the usefulness of CK isnfnrtns measured by a rapid 
10-min assay for detecting rcperfusioo withio I h after 
recanalizalion (8). Using CKMB isofonns. Puleo et al. (9) 
reported that 27 of 33 rcpctiitsed patients had a peak 
MBYhEBl ratio >3.8 compared with 5 of23 in the nnnreper- 
fused @ients (p < O.oOll. 
Because CK, CK-MM bofonos and myoglobin do not 
have myucardii speciIkity, detection of nperfusion using 
these noospechic markers might be unrellabk in palients 
with skeletal muxle inktrv. Increases in CK activity and _ 
myoglobin concentration in blocd have been reported in 
eases of shock or lrauma and in patients who received 
intramuscular injections, direct countershock or heart mas- 
sage (20.21). Myocardial-specitic markers might detect cor- 
onary reperfuskm more accurately than nonspecific markers 
in cases of superimposed skektal muscle injury. Creatioe 
kinase. MB isoensyme. including CK-MB isnfunns. is coo- 
sidercd a myocardird-specific enzyme; however, CK+lB is 
not found only in myocardium (22-25). The immunoinhibi- 
lion method using an unti-CK-M anttbody. us in our study, 
has been widely used to measure CK-MB activity in the 
emergency setting because of its short assay time using aa 
automatic chemical analyzer. However, this method is not 
always specific for CK-MB 126). Recently, immunoassay 
using monnclonal anti-CK-MB antibody was developed for 
rapid and accurate determination of CK-MB (27.28). 
Cardiac tmponin T is a contractile protein, structurally 
bound in cardiac muscle cells as cardiac myosin light chain. 
In contrast to cardiac myosin light chain (29). it has been 
reported that serum cardiac troponin T concentrations in- 
crease soon after the onset of acute myocardial infarction. 
similar to cytosolic proteins, such as CK (12-14). This 
phenomenon is probably explained by the washout of a 
soluble cytosolic troponin T pool (-6% of the total troponin 
T) (IS). In the present study. we confirmed marked washout 
of cardiac troponin T as well as CK-MB 60 min after 
treatment was initiated in the rep&used patients and could 
detect coronary reperfusion accurately using a threshold 
value of Atrooooin T of 0.50 &ml. Time from the initiation 
of treatment~to detection of &perfusion using our method 
(I h) was comparable to that using myoglobin or CK ISO- 
forms, that were considered more sensitive markers than CK 
or CK-MB (3,5.7-9). In our study. 4troponin T in the 
successfttl thmmbolytic therapy gmuQ had n tendency to be 
lower than that in coronary angioplasty group. The washuut 
of cardiac tmpunin T might be influenced more by th,: 
perfusion status of the infarct-related artery. However. in 
patients receiving successful thmmbolytic therapy. the sen- 
sitivity, specilicily and predictive accuracy I h afler initia- 
tioo of treatment were similar to those of patients receiving 
successful coronary angioplasty. Accordingly, Atroponin T 
closely r&cts the washout phenomenon fmm the necrotic 
mywardium during thmmbolytic therapy itis well as cure- 
nary aogioplasty. 
Because of its biily myocnrdial specificity, CK-MB has 
been widely wed in the emergency setting es the most 
reliable biochemical marker for acute myocardial infarction 
(30-32). Conversely. several investigators (12.33.34) have 
reported that cardiac tmponin T is o more highly specific 
myoeardial marker than CK-MB. Tmponin T is contained 
only in striated muscle cells sod is encoded by different 
genes in the mywardium and skeletal muscle. The isoforms 
of tmponin T in myaardium and skeletal muscle have 
si&icantly different protein structures (16.35.36). Katus et 
al. (12) found that cardiac tmpmin T increased over the 
upper limit of normal in w of patients with skeletal muscle 
injury, whereas CK.MB increased in 51%. Furthertoore. 
cardiac tmponin T showed no increase in patients undergo- 
ing lung surgery without perioprative myocardial infarc- 
tion. whereas CK-MB showed a significant increase in 42% 
of patients (33). 
The cmsweactivity of the cardiac tmponin T test devel- 
wed by Katus et al (Ig) with twified skeletal muscle 
t&o&t T was reported to be <O.i%. In the present study. 
we excluded patients with persistent shock and did not have 
any receiving direct countershock; however, cardiac tropo. 
nin T might be applicable to patients with massive skeletal 
muscle injury (34). To clarify the myocardial specificity 01 
cardiac tmpmin T in detecting coronary rewfusian, further 
asseswnent of cardiac tmpanin T in patients with skeletal 
muscle injury, such es shock or frequent intramuscular 
injection, or both. will be necessary. If cardiac troponin T 
shows the same release profile in patients with and without 
sk;!stal muscle injury, the usefulness of cardiac troponin T 
compared with other biochemical markers in detecting 
rcperfusion in these patients will be well established. 
Usefutness of Amen T 1 b event SE BL1 early 
index of reperfusto;. Serum cardiac troponin T levels 
showed a gradual increase and reached a peak 2 to 5 days 
after the onset of acute myocardial infarction in the non- 
reperfused patients. fn cootmst. serum cardiac troponin T 
reached a peak within I day after onset because of the 
washout phenomenon in repafused patients (15). Using the 
marked peak of serum cardiac tmpanin T soon atIer reper- 
fusion. Katus et al. (16) proposed a unique and reliable index 
of coronary repertusion. They reported that the ratio of 
serum cardiac tmoonin T I4 h to that 38 h after the onset of 
ncute myoctiiai infarction was 21.1 in the rep&used 
group. Using this criterion. the sensitivity and specificity for 
detecting repsrfusion were 9S% and 85% respectively (16). 
However. using their criterion. the presence or absence of 
coronary rcpcrfusian c~nnor be confirmed until 38 h after the 
onset of acute myocardial infarction. Because reperfusion 
within 6 h after onset of symptoms is desirable for myocnr- 
dial salv~;e (371, rescue coronary angioplasty or etnergeocy 
comnary bypass surgery should be performed as early as 
possible after failed thmmbolytic therapy, making it neces- 
sary to confirm the presence or absence of reperfusion soon 
after reperfusion therapy is initiated. Our method, based on 
the brrease in serum cardiac tmponin T soao after the 
initiation of treatment. can detect coronary reperfusion 
much earlier than can the 14.hf38-h ratio. Thus, our method 
is useful in detenoininc whether additional interventional 
therapy is necessary fo;myoardial salvage. 
Study limi(aliom. Because the present study involved 
only 38 patients, further large-scale,studies are required. to 
addition, hecnuse patients with skeletal muscle injury were 
not included in our study, we cannut prove the usefulness of 
myocardial-specific markers for detecting repelfusion in 
patients with skeletal muscle injury. Further investigations 
should include oatients with skeletal muscle injury. Our 
method may be &lictdt to apply to patients with intermittent 
coronary occlusion, spontaneous reperfusion before treat- 
ment and reocclusion early after successful reperfusion 
because the release profiles of intramyocardial pmteins. 
including cardiac tmponin T, may vary in these patients. We 
analyzed the data only in patients admitted between 2 and 
7 h after onset of acute myocardial infarction. Because 
washout ofcardiac troponin T and CK-MB in patients within 
2 h after onset may be lower than that in our subjects, our 
criteria for coronary repxfusion cannot be applied to these 
p&XltS. 
Using coronary angiogmphy, we excluded patients with 
spontaneous reperfusion and reocclusion patients from our 
study. Because it is difficult to distinguish spontaneous 
reperfusion in patients with intravenous tbrombolytic ther- 
ap) without performing coronary angiography, several non- 
invasive methods for detecting patients with spontaneous 
reperfusion have been proposed (38,391. Abe et al. (39) 
repotted that the sensitivity, specificity and predictive accu- 
racy for detecting spontaneous repafusion using the crite- 
don of mvo&dobinlCK >S.O were 15%. 96% and 92%. 
respeftively. Therefore, it is important to distinguish pa- 
tie& with Spamtaneous reperfusion as accurately as possible 
before the administration of thrombalvtic awnts when we 
apply our method clinically. 
Because the rate of increase in CK after rep&t&n has 
been rewrted to be an index of mvocardiaI infarct size l40). 
Atroponin T values may be inR&ced by infarct size (16). It 
is possible that Atropenin T in patients with a large myocar- 
dial infarction with persistently occluded coronary arteries 
may have higher values than patients with a small myocar- 
dial infarction with reperfwd coronary arteries. In the 
present sludy, infarct size in four patients showing Atropo- 
nin T CO.50 &ml could be small, because peak CK levels in 
these patients were significantly lower than those in the 
other 22 Patients. Therefore. the inlhtence of infarct size 
must be ionsidered when detecting reperfusion by our 
method. In contrast, because serutn cardiac tmpnin T 
shows a biohasic release motile in both small and law 
myowdiel infarctionr, the’lCMR-h ratio of cardiac I&- 
nin Treported by Katus et al. (IS,I6)is applicable regardless 
of the infarct size. 
Using the present enzyme immunoassay system, assay 
lime of cardiac tfopnin T is -90 min (18). too long for M 
emergency laboratory. Even if coronary repelfusion is de- 
tectable 60 min aftertrealment is initiated using Atmmmin T. 
the results are not available until -2.5 h a!?c~tre&ent. In 
contra% CK-MB can be= measured more rapidly than car- 
diac lroponin T. Assay time of CK-MB is 1030 min with the 
immun~inbibition method using anli-CK-M antibody (26) or 
with the immunoassav using anti-CK-MB antibodv 127.28). 
A faster test method ii needed for cardiac troponin T to 
establish itself as a routine test in clinical practice and to 
benefit from its characteristics BS an early and specific index 
of repfusion. 
Conchwlon. The increased level of cardiac tmponin T I h 
afler initiation of treatment is an early index for assessmcnl 
of reperfusion therapy in patients undergoing thrombalytic 
therapy as well as coronary angioplasty. 
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